Go Deep
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -19,507 | -15.2 | -1.66 | -0.62 | 345.71 |
| Oct 2026 | -20,470 | -18.4 | -2.01 | -0.62 | 418.64 |
| Oct 2026 | -22,558 | -19.4 | -2.11 | -0.62 | 440.90 |
| Oct 2026 | -22,683 | -19.8 | -2.16 | -0.62 | 450.38 |
| Oct 2026 | -22,596 | -19.5 | -2.12 | -0.62 | 442.63 |
| Oct 2026 | -22,358 | -18.7 | -2.04 | -0.62 | 423.81 |
Cryo-Cell International, Inc. Quarterly Results
| Line Item | May 2026 | Feb 2026 | Nov 2025 | May 2025 |
|---|---|---|---|---|
| Revenue | 7,776,113.0 | 7,683,117.0 | 7,843,166.0 | 7,928,843.0 |
| Net Profit | 554,586.0 | 47,108.0 | -3,817,433.0 | 355,785.0 |
| EPS | 0.1 | 0.0 | — | 0.0 |
Cryo-Cell International, Inc. Revenue & Profit: Last 5 Years
| Line Item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
| Revenue | 31,566,321.0 | 31,986,106.0 | 31,343,695.0 | 30,336,749.0 | — |
| Net Profit | -2,429,385.0 | 402,095.0 | -9,521,669.0 | 2,771,408.0 | — |
| EPS | -0.3 | 0.1 | -1.1 | 0.3 | — |
Cryo-Cell International, Inc. Balance Sheet
| Line Item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
| Total Assets | 61,728,514.0 | 64,677,633.0 | 61,220,770.0 | 64,888,054.0 | — |
| Total Liabilities | 80,334,443.0 | 77,893,650.0 | 72,252,002.0 | 66,412,356.0 | — |
| Total Equity | -18,605,929.0 | -13,216,017.0 | -11,031,232.0 | -1,524,302.0 | — |
Owes vs Owns
Cryo-Cell International, Inc. owed $1.29 for every $1 it owned in May 2026, up from $1.02 in Nov 2022.
| Period | May 2026 | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.29× | 1.30× | 1.20× | 1.18× | 1.02× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Cryo-Cell International, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Nov 2025
Cash & short-term investments 5.3%Receivables 11.1%Inventory 0.7%Fixed assets (tangible) 35.4%Intangible assets 4.5%Other assets 43.0%
How it's funded — Nov 2025
Short-term debt 3.1%Long-term debt 10.2%Payables 3.6%Other liabilities 83.2%
| Line Item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3.3 | 3.5 | 1.0 | 1.7 |
| Receivables | 6.8 | 7.3 | 6.6 | 6.0 |
| Inventory | 0.4 | 0.7 | 0.8 | 0.9 |
| Fixed assets (tangible) | 21.9 | 22.7 | 22.0 | 14.2 |
| Intangible assets | 2.8 | 2.9 | 2.9 | 17.1 |
| Long-term investments | 0.0 | 0.0 | 0.3 | 0.3 |
| Other assets | 26.5 | 27.7 | 27.6 | 24.7 |
| Liabilities & equity | ||||
| Short-term debt | 2.5 | 3.7 | 1.4 | 2.4 |
| Long-term debt | 8.2 | 8.3 | 8.4 | 8.6 |
| Payables | 2.9 | 1.9 | 3.2 | 1.6 |
| Other liabilities | 66.8 | 64.0 | 59.3 | 53.8 |
| Shareholders' equity | -18.6 | -13.2 | -11.0 | -1.5 |
| Net tangible assets | -21.4 | -16.1 | -14.0 | -18.6 |
Cryo-Cell International, Inc. Cash Flow
| Line Item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
| Operating Activities | 5,478,606.0 | 6,010,910.0 | 8,919,754.0 | 8,572,647.0 | — |
| Investing Activities | -975,332.0 | -4,876,899.0 | -8,144,754.0 | -15,279,639.0 | — |
| Financing Activities | -4,745,203.0 | -979,118.0 | -2,072,891.0 | 147,862.0 | — |